Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares Issued
Growth Metrics
Income Statement
Others
Ratios

Avai Bio (AVAI) Change in Accured Expenses (2020 - 2023)

Avai Bio's Change in Accured Expenses history spans 3 years, with the latest figure at $440000.0 for Q4 2023.

  • On a quarterly basis, Change in Accured Expenses rose 1034.75% to $440000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $647309.0, a 9342.87% increase, with the full-year FY2023 number at -$2816.0, down 102.33% from a year prior.
  • Change in Accured Expenses hit $440000.0 in Q4 2023 for Avai Bio, up from -$48600.0 in the prior quarter.
  • Over the last five years, Change in Accured Expenses for AVAI hit a ceiling of $440000.0 in Q4 2023 and a floor of -$61500.0 in Q3 2022.
  • Historically, Change in Accured Expenses has averaged $73770.6 across 3 years, with a median of $9771.0 in 2020.
  • The widest YoY moves for Change in Accured Expenses: up 1034.75% in 2023, down 20.98% in 2023.
  • Tracing AVAI's Change in Accured Expenses over 3 years: stood at -$420.0 in 2020, then surged by 9332.14% to $38775.0 in 2022, then skyrocketed by 1034.75% to $440000.0 in 2023.
  • Business Quant data shows Change in Accured Expenses for AVAI at $440000.0 in Q4 2023, -$48600.0 in Q3 2023, and $266000.0 in Q2 2023.